206 related articles for article (PubMed ID: 31496051)
1. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.
Yotebieng M; Mpody C; Ravelomanana NL; Tabala M; Malongo F; Kawende B; Ntangu P; Behets F; Okitolonda E;
J Int AIDS Soc; 2019 Sep; 22(9):e25376. PubMed ID: 31496051
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study.
Mpody C; Thompson P; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
PLoS One; 2019; 14(5):e0216293. PubMed ID: 31071145
[TBL] [Abstract][Full Text] [Related]
3. Continuous quality improvement interventions to improve long-term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: design of an open-label, parallel, group randomized trial.
Yotebieng M; Behets F; Kawende B; Ravelomanana NLR; Tabala M; Okitolonda EW
BMC Health Serv Res; 2017 Apr; 17(1):306. PubMed ID: 28446232
[TBL] [Abstract][Full Text] [Related]
4. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C prevalence and quality of health services among HIV-positive mothers in the Democratic Republic of the Congo.
Thompson P; Mpody C; Sayre W; Rigney C; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
Sci Rep; 2022 Jan; 12(1):1384. PubMed ID: 35082320
[TBL] [Abstract][Full Text] [Related]
6. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
[TBL] [Abstract][Full Text] [Related]
7. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
[TBL] [Abstract][Full Text] [Related]
9. Timing of HIV testing among pregnant and breastfeeding women and risk of mother-to-child HIV transmission in Malawi: a sampling-based cohort study.
Chagomerana MB; Edwards JK; Zalla LC; Carbone NB; Banda GT; Mofolo IA; Hosseinipour MC; Herce ME
J Int AIDS Soc; 2021 Mar; 24(3):e25687. PubMed ID: 33749155
[TBL] [Abstract][Full Text] [Related]
10. Association of comprehensiveness of antiretroviral care and detectable HIV viral load suppression among pregnant and postpartum women in the Democratic Republic of the Congo: a cross-sectional study.
Boisson-Walsh A; Ravelomanana NLR; Tabala M; Malongo F; Kawende B; Babakazo P; Yotebieng M
Front Glob Womens Health; 2024; 5():1308019. PubMed ID: 38903153
[TBL] [Abstract][Full Text] [Related]
11. Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa.
Moyo F; Mazanderani AH; Kufa T; Sherman GG
S Afr Med J; 2021 Apr; 111(5):469-473. PubMed ID: 34852890
[TBL] [Abstract][Full Text] [Related]
12. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
15. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
Yotebieng M; Thirumurthy H; Moracco KE; Edmonds A; Tabala M; Kawende B; Wenzi LK; Okitolonda EW; Behets F
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S124-9. PubMed ID: 27355499
[TBL] [Abstract][Full Text] [Related]
16. HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo.
Zotova N; Familiar I; Kawende B; Kasindi FL; Ravelomanana N; Parcesepe AM; Adedimeji A; Lancaster KE; Kaba D; Babakazo P; Yotebieng M
J Int AIDS Soc; 2022 Feb; 25(2):e25865. PubMed ID: 35129301
[TBL] [Abstract][Full Text] [Related]
17. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
18. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa.
Woldesenbet SA; Kufa T; Barron P; Chirombo BC; Cheyip M; Ayalew K; Lombard C; Manda S; Diallo K; Pillay Y; Puren AJ
AIDS; 2020 Mar; 34(4):589-597. PubMed ID: 31821189
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveys.
Schrubbe LA; Stöckl H; Hatcher AM; Marston M; Kuchukhidze S; Calvert C
AIDS; 2023 Mar; 37(4):659-669. PubMed ID: 36511117
[TBL] [Abstract][Full Text] [Related]
20. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Joseph Davey DL; Pintye J; Baeten JM; Aldrovandi G; Baggaley R; Bekker LG; Celum C; Chi BH; Coates TJ; Haberer JE; Heffron R; Kinuthia J; Matthews LT; McIntyre J; Moodley D; Mofenson LM; Mugo N; Myer L; Mujugira A; Shoptaw S; Stranix-Chibanda L; John-Stewart G;
J Int AIDS Soc; 2020 Jan; 23(1):e25426. PubMed ID: 31912985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
